Introduction

Risk disclosure adequacy standards determine whether a patient or research participant has received sufficient, accurate, and understandable information about the risks of a medical procedure, drug, or experimental treatment before consenting to it. The purpose is to ensure that consent is voluntary and informed, rather than merely a signature on a consent form.

In India, adequate risk disclosure is closely connected with the right to bodily autonomy, dignity, and personal liberty under Article 21 of the Constitution. It is also a fundamental element of medical ethics and the law of negligence. A doctor or researcher must explain the nature and purpose of an intervention, its expected benefits, significant risks, available alternatives, and the likely consequences of refusing treatment.

However, adequacy does not mean disclosing every imaginable or remote danger. The information must be sufficient to allow a balanced decision, while avoiding unnecessary confusion. The required level of disclosure depends on the treatment, the patient’s condition, the seriousness of the risks, and the available scientific evidence.

Legal Standards and Case Laws

1. Samira Kohli v. Dr. Prabha Manchanda, (2008) 2 SCC 1

The Supreme Court established the leading Indian standard for adequate disclosure in medical treatment. It held that consent must be voluntary, given by a competent person, and based on adequate information.

The doctor should disclose the nature and purpose of treatment, its benefits and effects, available alternatives, substantial risks, and adverse consequences of refusing treatment. Remote or merely theoretical risks need not invariably be disclosed. The Court also clarified that consent for a diagnostic procedure does not automatically authorise a different therapeutic procedure.

Indian Kanoon+1

2. Yash Charitable Trust v. Union of India, 2026 INSC 96

In this judgment concerning stem-cell interventions for Autism Spectrum Disorder, the Supreme Court explained that adequate disclosure depends upon the availability of reliable scientific information. Where the safety and efficacy of an intervention are not established, doctors may lack the necessary evidence to provide adequate information in the first place.

The Court emphasised that claimed informed consent cannot by itself justify offering unproven interventions as routine medical treatment. This case is particularly relevant to biotechnology and experimental therapies, where disclosure must include scientific uncertainty and the absence of established evidence.

Sci API+1

3. K.S. Puttaswamy v. Union of India, (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right rooted in dignity and personal autonomy. Although the case was not directly about medical risk disclosure, its constitutional reasoning supports the principle that individuals should retain meaningful control over decisions affecting their bodies and personal information. It provides a constitutional foundation for protecting voluntary medical decision-making.

Essential Elements of Adequate Disclosure

A proper disclosure process should include:

Nature of intervention: What procedure or treatment will be performed.

Material risks: Significant complications, including their seriousness and likelihood where known.

Benefits and limitations: Expected outcomes without guaranteeing success.

Alternatives: Other reasonable treatment options, including no treatment where relevant.

Scientific uncertainty: Incomplete evidence, experimental status, and unknown long-term effects.

Comprehensibility: Plain language, suitable explanations, and an opportunity to ask questions.

A written consent form is useful evidence, but it does not automatically establish that adequate disclosure occurred. The quality of the explanation and the patient’s understanding remain important.

Conclusion

Risk disclosure adequacy standards protect patients from uninformed medical decisions and help maintain trust in healthcare. Samira Kohli provides the principal Indian legal test, while Yash Charitable Trust demonstrates its importance in experimental biotechnology. Adequate disclosure must be relevant, evidence-based, understandable, and proportionate to the risks involved. It is an essential condition of valid consent and ethical medical practice.

Indian Kanoon+1